Type of glycemic control is more important than tight glycemic control
ESC HF 2017 Diabetes worsens risk associated with various CV conditions. Prof. David Fitchett considers the therapeutic options to minimise this CV risk and the increasing role of cardiologists in current optimal management of CV patients with diabetes.
Educational information
This video was recorded during ESC HF 2017, April 29 - May 1 in Paris, France. PACE-cme did not receive financial support for the production of this video.
The educational content reflects the personal opinion of the expert.
Disclosures
Prof. David Fitchett - University of Toronto, Toronto, Ont, Canada
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: